Back to Bills

Routine Mammograms Available From Age 40

Full Title:
The Earlier Screening for Breast Cancer Act

Summary#

This Manitoba law lowers the starting age for routine breast cancer screening to 40. It lets people get a screening mammogram through the BreastCheck program without a doctor’s referral. It also requires the government to report each year on progress and on how many screenings were done. The law took effect when it received royal assent.

  • Lowers the eligibility age for routine BreastCheck screening from 50 to 40, no referral needed, by December 31, 2026.
  • Requires the health minister to create and carry out a plan to make this change.
  • Orders an annual public report on the plan’s status and the number of screening mammograms done each year.
  • The minister must table the report in the Legislature; this reporting ends five years after the age is lowered.
  • The act does not set out funding or clinic details.

What it means for you#

  • Adults 40–49 in Manitoba:
    • By December 31, 2026, you will be able to book a routine screening mammogram through BreastCheck without a doctor’s note.
  • Adults 50 and older:
    • No change to your current access. You can continue to use BreastCheck for routine screening without a referral.
  • All residents:
    • The government must publish a yearly update on progress and how many screening mammograms were done. This improves public transparency.
  • Timeline:
    • The change must be in place by the end of 2026. Until then, current rules stay the same.

Expenses#

Estimated annual cost: No publicly available information.

  • The act does not include funding details or cost estimates.

Proponents' View#

  • Starting screening at 40 can find breast cancer earlier, when treatment often works best.
  • Dropping the referral requirement removes a barrier, especially for people without a regular doctor.
  • A clear deadline (end of 2026) pushes the system to be ready on time.
  • Annual public reporting builds transparency and helps track access and results.

Opponents' View#

  • Screening people in their 40s can lead to more false alarms, extra tests, and stress for patients.
  • More screening may strain clinics and staff, which could lengthen wait times for everyone if capacity does not grow.
  • Costs could rise without new funding or staff.
  • Some health experts argue resources should focus on higher‑risk and older age groups, where benefits are clearer.